Valuation: UCB

Market Cap 46.83B 53.32B 43.55B 39.96B 75.09B 5,135B 76.24B 517B 202B 2,524B 200B 196B 8,728B P/E 2026 *
26.4x
P/E 2027 * 20.9x
Enterprise Value 46.59B 53.04B 43.32B 39.76B 74.7B 5,108B 75.85B 514B 201B 2,511B 199B 195B 8,683B EV / Sales 2026 *
5.45x
EV / Sales 2027 * 4.62x
Free-Float
61.59%
Yield 2026 *
0.6%
Yield 2027 * 0.61%
1 day+1.23%
1 week+2.80%
Current month-6.11%
1 month-3.53%
3 months+2.93%
6 months-4.43%
Current year+3.10%
1 week 235.7
Extreme 235.7
249.8
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 177.7
Extreme 177.7
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 31/12/2014
Director of Finance/CFO 59 30/06/2020
Chief Tech/Sci/R&D Officer 59 30/04/2024
Director TitleAgeSince
Director/Board Member 55 31/12/2011
Director/Board Member 67 31/12/2014
Director/Board Member 56 23/04/2014
Date Insider Type Main position Quantity % Market Cap.
15/01/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
15/01/26 Buy

Director

500 0.0003%
15/01/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+2.80%+37.51%+202.14% 53.32B
+0.63%-3.06%+16.18%-9.78% 66.74B
+10.08%+51.80%+51.80%+51.80% 48.12B
-1.32%-7.38%-57.63%-57.10% 38.25B
+0.78%-1.84%+52.49%-27.01% 29.85B
+0.84%+0.36%+66.93%+85.42% 23.51B
-5.17%-12.54%+58.98%-56.04% 21.45B
-1.21%+1.12%+1.98%+170.93% 19.97B
-0.22%-0.95%+61.97%+123.78% 16.38B
+1.31%+3.24%+84.01%+152.77% 16.47B
Average +1.29%-0.57%+37.42%+63.69% 33.41B
Weighted average by Cap. +1.78%+0.06%+30.57%+55.05%

Financials

2026 *2027 *
Net sales 8.54B 9.73B 7.95B 7.29B 13.7B 937B 13.91B 94.35B 36.86B 461B 36.52B 35.73B 1,592B 9.64B 10.98B 8.97B 8.23B 15.46B 1,057B 15.7B 106B 41.61B 520B 41.22B 40.33B 1,797B
Net income 1.77B 2.02B 1.65B 1.51B 2.84B 194B 2.88B 19.55B 7.64B 95.42B 7.57B 7.4B 330B 2.28B 2.59B 2.12B 1.94B 3.65B 250B 3.71B 25.15B 9.82B 123B 9.73B 9.52B 424B
Net Debt -242M -276M -225M -207M -388M -26.56B -394M -2.67B -1.05B -13.06B -1.04B -1.01B -45.14B -2.32B -2.65B -2.16B -1.98B -3.73B -255B -3.78B -25.66B -10.02B -125B -9.93B -9.72B -433B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
24/07/26 €246.00 +1.23% 149,516
23/07/26 €243.00 -0.12% 205,984
22/07/26 €243.30 -0.25% 107,748
21/07/26 €243.90 +2.48% 198,029
20/07/26 €238.00 -0.54% 155,998
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
246.00EUR
Average target price
287.95EUR
Spread / Average Target
+17.05%

Quarterly revenue - Rate of surprise